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Abstract
The bloodstream developmental forms of pathogenic African trypanosomes are uniquely susceptible to killing by small
hydrophobic peptides. Trypanocidal activity is conferred by peptide hydrophobicity and charge distribution and results
from increased rigidity of the plasma membrane. Structural analysis of lipid-associated peptide suggests a mechanism of
phospholipid clamping in which an internal hydrophobic bulge anchors the peptide in the membrane and positively
charged moieties at the termini coordinate phosphates of the polar lipid headgroups. This mechanism reveals a necessary
phenotype in bloodstream form African trypanosomes, high membrane fluidity, and we suggest that targeting the plasma
membrane lipid bilayer as a whole may be a novel strategy for the development of new pharmaceutical agents.
Additionally, the peptides we have described may be valuable tools for probing the biosynthetic machinery responsible for
the unique composition and characteristics of African trypanosome plasma membranes.
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Introduction
Eukaryotic pathogens of the genus Trypanosoma cause deadly
disease in humans and livestock. Human African trypanosomiasis,
or sleeping sickness, is caused by two subspecies, Trypanosoma brucei
rhodesiense, causing an acute disease, or Trypanosoma brucei gambiense,
causing a chronic infection [1]. Nagana, an economically de-
bilitating wasting disease in African cattle is caused by Trypanosoma
brucei brucei and other species including Trypanosoma vivax and
Trypanosoma congolense [2]. Trypanosoma vivax infection in cattle has
also been established in South America [3]. African trypanosomes
exhibit several life stages including a bloodstream form (BSF) in
the circulation of the mammalian host, a procyclic form (PCF) in
the midgut of the tsetse fly vector and a metacyclic form that is
injected during fly-feeding and initiates infection [4].
Drug development is difficult for a number of reasons, both
biological and economic, and resistance is also a major problem [5].
Higher primates are innately immune to veterinary pathogenic
African trypanosomes due to circulating trypanolytic factors [6,7].
However African trypanosomes have evolved a variety of mechan-
isms to evade innate and acquired immunity. The best-understood
mechanism is successive expression of antigenically distinct glycer-
ophosphotidylinositol-anchored (GPI-) variant surface glycopro-
teins (VSG) [8]. Another strategy is clearance of surface bound host
defense factors. The most striking example of this is the hydrody-
namic flow-mediated lateral sorting of Ig-bound-VSG to the
flagellar pocket, an invagination at the posterior of the cell that is
the sole site for endocytosis [9].
Previously we demonstrated that both veterinary and human
pathogenic BSF T. brucei are uniquely susceptible to killing by two
small hydrophobic peptides (SHP), SHP-1 and -2 [10]. Specificity
of SHP is mediated by a high degree of fluidity in the plasma
membrane of BSF cells [10]. These peptides do not bind, and thus
do not kill, PCF T. brucei, which has a more rigid plasma
membrane. Human cells, including erythrocytes, are refractory to
SHP concentrations orders of magnitude higher than necessary to
kill BSF T. brucei [10].
Here we report that trypanocidal SHP uniquely cause an
increase in the rigidity of the interfacial region of the plasma
membrane that is consistent with dramatic motility constriction
and subsequent cell death. We present an explanation, based upon
sequence analysis and the orientation and structure of lipid
associated SHP, for these biophysical consequences.
Results
Susceptibility to SHP is Independent of VSG and
Common to African Trypanosomes
An immediately apparent difference between the plasma
membranes of BSF and PCF African trypanosomes is the lack of
a dense coat of VSG in the insect stage cells. We tested metacyclic
T. b. brucei, which do express a VSG coat, for susceptibility to SHP-
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1 and found no killing activity (Fig. 1a). These data indicate that
susceptibility is not due to specificity of SHP for VSG. Next we
determined whether other African trypanosomes are sensitive to
SHP. Bloodstream developmental forms of T. vivax and T.
congolense are susceptible to killing by SHP-1 at concentrations
similar to BSF T. brucei (Fig. 1b), indicating that SHP susceptibility
is a characteristic of both human and veterinary pathogenic
African trypanosomes.
Trypanocidal Activity Requires a C-terminal Positive
Charge
Trypanocidal SHP are derived from apolipoproteins and
exhibit the characteristics of secretory signal peptides, i.e. size
(18–22 amino acids), a central hydrophobic region and a C-
terminal putative signal peptidase cleavage site defined by
specific amino acid patterns [10]. Although these peptides share
physical features, the primary sequences are entirely different
(Fig. 1c). We tested a third, distinct SHP (23) for trypanocidal
activity, also derived from an apolipoprotein [11] and possessing
similar features as SHP-1 and -2 (Fig. 1c). Despite possessing the
same general physical characteristics and binding to BSF T. brucei
(Methods File S1, Figure S1), no trypanocidal activity was
detected (Fig. 1d). Comparison of the three sequences revealed
that an arginine at position -5 relative to the C-terminus is
common to trypanocidal SHP-1 and -2, but is absent in SHP-3
(Fig. 1c). Substitution of an arginine for the leucine in this
position of SHP-3 (SHP-3DR, Fig. 1c) confers trypanocidal
activity (Fig. 1d). Replacement of the leucine with glutamate in
SHP-3 (SHP-3DE, Fig. 1c) does not (Fig. 1d). Trypanocidal
activity is conferred simply by a positive charge at the C-
terminus, indicated by the trypanocidal activity of an SHP-3
variant in which the -5 leucine is replaced by lysine (SHP-3DK,
Fig. 1d). Trypanocidal SHP-2 has a positive charge at both the
N- and C-terminus, SHP-1 has a single positive charge at the C-
terminus; thus we tested whether charge location is important by
swapping the C-terminal arginine with the N-terminal aspartate
of SHP-1 (SHP-1-swap, Fig. 1c). Rearranging these residues
resulted in a loss of trypanocidal activity (Fig. 1d).
Trypanocidal SHP Rigidify the Interior and Interfacial
Region of the Plasma Membrane
Trypanocidal SHP act at the plasma membrane but do not
induce osmotic swelling or bursting [10]. Therefore we reasoned
that any effect upon the BSF trypanosome must not result in a loss
Figure 1. Small hydrophobic peptide mediated killing of African trypanosomes. (a) The metacyclic developmental form (the
developmental stage injected during a tsetse fly bite) of T. b. brucei was assayed for susceptibility to SHP-1 in 2 h in vitro killing assays (green X,
metacyclic; orange&, BSF). (b) The veterinary pathogenic African trypanosomes, T. vivax (red&, SHP-1; red-open%, DMSO) and T. congolense (blue
m, SHP-1; blue-open n, DMSO), were assayed for susceptibility to SHP-1 in 2 h in vitro killing assays. (c) The sequences of trypanolytic and non-
trypanolytic SHP are shown from N- to C-terminus and aligned to the C-terminus in order to emphasize the identity of the amino acid at position -5
relative to the putative signal peptidase cleavage site. Positively charged amino acids are in red, negatively charged amino acids are in green and
non-polar amino acids are underlined. (d) The SHP listed in (c) were tested against BSF T. b. brucei in 2 h killing assays (blue N, SHP-1; red&, SHP-3;
green m, SHP-3DR; purple &, SHP-3DK; orange m, SHP-3DE; black N, SHP-1swap). Colors correspond to the peptide names in (c).
doi:10.1371/journal.pone.0044384.g001
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of plasma membrane integrity. We investigated the rigidity of BSF
T. brucei membranes, a property that can change without loss of
membrane integrity, utilizing two anisotropic probes, diphenyl-
hexatriene (DPH) that reports on the interior of the acyl chain
region, and trimethylammonium-diphenylhexatriene (TMA-DPH)
that is anchored at the membrane interface. Addition of either
trypanocidal or non-trypanocidal SHP to BSF T. brucei results in
increased rigidity of the interior of the plasma membrane (Fig. 2a).
However only the trypanocidal SHP, SHP-1, -2, -3DR and -3DK
increased the interfacial rigidity (Fig. 2b). These data indicate that
rigidification of the interfacial region is likely involved in killing
BSF trypanosomes.
Trypanocidal SHP have Biophysical and Physiological
Consequences
Treatment of BSF African trypanosomes with SHP results in
multiple physiological alterations. Addition of SHP-1 to BSF
trypanosomes, which were subsequently immobilized in gelatin,
decreases the fraction of laterally mobile surface exposed VSG
(Fig. 2c). This effect may be directly due to increased
membrane rigidity, or indirectly due to a decrease in the
mobility of membrane spanning proteins and potential interac-
tions with the VSG. Another physiological consequence, that
may or may not be related to membrane rigidification, is SHP-
induced changes in cell motility. Previously we reported that
SHP-1 causes an initial hyperactivation followed by constricted
motility and death [10]. Non-trypanocidal SHP-3 does cause
some hyperactivation of BSF T. b. brucei (Movie S1 displays an
untreated cell for comparison, Movie S2 presents a representa-
tive cell exhibiting SHP-3 induced hyperactivation), however
subsequent constriction does not occur (Fig. 2d). Trypanocidal
SHP-1 [10] and SHP-3DR (Movie S3, S4) induce both
hyperactivation and subsequent constriction (Fig. 2d). Con-
stricted motility may result in reduced hydrodynamic forces
acting upon surface proteins.
Figure 2. Membrane rigidity changes and physiological consequences of SHP. The rigidity of the interior (a) or interfacial (b) region of the
plasma membrane of BSF T. b. brucei treated with increasing concentrations of SHP-1 (blue N), SHP-2 (greyX), SHP-3 (red&), SHP-3DR (green m),
SHP-3DK (purple m), SHP-3DE (orange-open n), SHP-1swap (black-open #) or solvent alone (DMSO, black6) was determined by measuring the
fluorescence depolarization of DPH or TMA-DPH respectively. (c) FRAP analysis of the mobile fraction of BSF T. b. brucei VSG in the presence (red&)
or absence (black &) of 8 mM SHP-1. (d) Live BSF T. b. brucei treated with equivolume DMSO (grey), 40 mM SHP-1 (blue), SHP-3 (red) or SHP-3DR
(green) were visualized by DIC microscopy and scored for normal, hyperactivated and constricted motility as well as death at the indicated timepoints
(see Movies S1, S2, S3 and S4 for examples of the normal, hyperactivated and constricted motilities respectively).
doi:10.1371/journal.pone.0044384.g002
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Trypanocidal SHP Exhibit Shallow Penetration and Orient
Perpendicular to the Plane of the Membrane
In order to understand why trypanocidal and non-trypanocidal
SHP have different effects on the BSF plasma membrane, we
determined the orientation of SHP-1 and -3 in lipid bilayers by
parallax analysis [12]. Tryptophans were substituted at positions 1,
8 and 18 (N- to C-terminus, native tryptophan located at position
12) in SHP-1 and positions 1, 13 and 20 in SHP-3 (N- to C-
terminus, native tryptophan located at position 5) (Table S1).
These placements were chosen, and native tryptophan residues
were replaced with glycine, in order to retain the hydrophobic
profile of the original peptides. All of the substituted SHP-1
peptides show equivalent killing activity as well as membrane
interaction (Methods File S1, Figure S2a, b). We determined the
insertion depth of SHP tryptophans by ratiometric analysis of the
quenching efficiency of liposomes containing 10 mol % bromi-
nated lipid at a shallow (6,7) and deep (9,10) position of the acyl
chains. Trypanocidal SHP-1 penetrates shallowly into the
hydrocarbon region and adopts a U-shaped conformation (Fig. 3a,
Table S1). The two terminal tryptophans, positions 1 and 18, are
located approximately 1.1 and 2.0 A˚ from the membrane interface
respectively. The tryptophans at positions 8 and 12 are located
approximately 7.8 and 5.1 A˚ from the interface respectively.
Therefore, rather than aligning with the phospholipid acyl chains,
SHP-1 inserts into the exterior leaflet parallel to the plane of the
bilayer and proximal to the phospholipid headgroups. These data
are consistent with an orientation that has been observed for the
LamB signal peptide [13,14]. Non-trypanocidal SHP-3 and the
tryptophan variants also exhibit membrane interaction (Figure
S2c). Parallax analysis of SHP-3 indicates a tilted orientation with
the C-terminus penetrating deeper into the bilayer, an orientation
that has also been suggested for the LamB signal peptide (Fig. 3a,
Table S1) [13]. The N-terminal tryptophan was inefficiently
quenched, suggesting that it does not intercalate into the
hydrocarbon region. The native tryptophan, position 5, inserts
approximately 1.6 A˚ deep. The tryptophan at position 13 is
located approximately 4.7 A˚ deep and the C-terminal tryptophan
penetrates most deeply, to approximately 11.2 A˚. This orientation
precludes interaction of the C-terminus with the lipid headgroups.
Trypanocidal SHP Adopt a-helical Structures with
Positively Charged Patches at Both Termini
Circular dichroism spectroscopy reveals different structures for
soluble and lipid-associated SHP-1. In the solution spectrum, the
peak at 195 nm, crossover at approximately 205 nm and
minimum at 218 nm are characteristic of a b-sheet conformation
(Fig. 3b) [15]. In the presence of lipid, the peak at 193 nm and
minimum at 208 nm suggest that SHP-1 adopts an a-helical
structure (Fig. 3b) [15], again consistent with the secondary
structure of the LamB signal peptide [16]. The structural analysis
and parallax data are consistent with a predicted structure from
molecular dynamics simulations, in which SHP-1 adopts a helix-
break-helix, a motif reported for lipid associated PhoE signal
peptide [17]. The free amino-group at the N-terminus and the C-
terminal arginine form positively charged patches at both termini
and the interior region forms a hydrophobic bulge (Fig. 3c).
Discussion
Changes in membrane rigidity as measured by fluorescence
anisotropy have been shown to correlate with alterations in
cellular physiology and biochemistry. Temperature induced
rigidification of platelet membranes results in a concomitant
decrease in fluid phase endocytosis [18]. Additionally in the type 1
diabetic disease state platelets exhibit an increase in the rigidity of
the interior of the plasma membrane that results in a decrease in
Na+/K+-ATPase activity [19]. In the case of BSF African
trypanosomes, we have correlated increased membrane rigidity
with changes in cell motility, the diffusion of rate of surface
proteins and ultimately cell death. Therefore, membrane rigidi-
fication may be trypanocidal by interfering with a variety of
activities such as, but not limited to, lateral surface protein
diffusion, ion channel function and/or the diffusion of small
molecule nutrients into the BSF cell. It has been shown that
increasing the rigidity of trypanosome membranes results in
a redistribution of proteins normally localized to the flagellar
membrane [20], posing the possibility that signaling pathways may
be affected. Therefore trypanocidal SHP may have pleiotropic
effects.
Figure 3. Orientation and structure of SHP in lipid bilayers. (a) The depth of peptide penetration into the hydrocarbon region of model
liposomes was determined via parallax analysis. Assuming a hydrocarbon bilayer thickness of 29 A˚, the depths of tryptophans spanning SHP-1 (blueN) and SHP-3 (red &) are plotted against a background of the outer leaflet of a POPC bilayer. (b) Circular dichroism spectroscopy of SHP-1 in
aqueous buffer (green N) and in the presence of egg phosphatidylcholine liposomes (blue N). (c) Molecular dynamic modeling of SHP-1 in a lipid
environment. The backbone trace (top) illustrates a predominantly a-helical structure with disordered termini and an internal disordered region.
Surface potential representations (N to C terminal, middle; C to N terminal, bottom) indicate positively charged patches (blue) formed by the N-
terminal amino acid and the arginine at position 14. Non-polar and negatively charged regions are shown in white and red, respectively.
doi:10.1371/journal.pone.0044384.g003
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In addition to directly killing BSF trypanosomes, SHP induce
physiological changes that may attenuate the parasites’ ability to
evade host immune effectors. The diffusion of VSG is altered in
trypanosomes treated with SHP-1. The decrease in the number of
mobile surface VSG may be due to increased membrane rigidity
conferring greater drag upon the myristate anchors. Alternatively,
or in addition to, increased membrane rigidity may hinder VSG
diffusion through decreasing the mobility of membrane spanning
proteins that subsequently interfere with the lateral surface flow of
VSG. In either case hindering the flow of VSG to the flagellar
pocket would likely delay the clearance of host defense molecules
thereby promoting cell killing. Additionally, constricting the
motility of BSF trypanosomes may effectively decrease hydrody-
namic flow over the surface of the cell, a force necessary for
maintaining directionality and movement of VSG to the anterior
of the trypanosome [9], also delaying the clearance of VSG.
Employing agents that increase the rigidity of the plasma
membrane in pharmaceutical applications may therefore augment
the host immune response to trypanosome infection.
The orientation of trypanocidal SHP in lipid bilayers differs
from non- trypanocidal SHP in that both termini are proximal to
the membrane interface. This orientation can be attributed to
a positively charged residue at the -5 position relative to the C-
terminus that is lacking in non- trypanocidal SHP. Swapping
a negatively charged residue for the C-terminal arginine (SHP-
1swap) will result in a similar hydrophobic profile and thus
presumably induce the same orientation in lipid bilayers, however
this change renders the SHP incapable of rigidifying the
membrane interface and therefore non- trypanocidal. These data
indicate a direct role for a C-terminal positively charged residue
(arginine or lysine) in increasing interfacial rigidity and trypano-
some killing. Incorporating the requirement for a positive charge
at the C-terminus and the hydrophobic bulge revealed by
molecular dynamic modeling, we suggest a mechanism in which
trypanocidal SHP are anchored in the membrane hydrocarbon
region by the internal hydrophobic stretch and the positively
charged patches at each termini coordinate negatively charged
phosphates of the lipid headgroups. This model provides
a plausible explanation for the increase in interfacial membrane
rigidity by trypanocidal but not non- trypanocidal SHP.
The specificity of SHP for BSF African trypanosomes reveals
a phenotype that may be taken advantage of for the development
of pharmaceutical agents. Drugs that target the fluidity of the
plasma membrane may offer a means of circumventing the rapid
onset of resistance exhibited by these pathogens. Compensating for
a phenotype that is the result of a system of gene products would
require multiple viable mutations rather than a single mutation
within a targeted enzyme or transporter. Additionally SHP may be




All peptides were purchased from Bio-Synthesis, Inc. (Lewis-
ville, TX). All lipids were purchased from Avanti Polar Lipids
(Alabaster, AL). These include phosphatidylcholine from egg
(8450051) and 1-palmitoyl-2-(6,7-dibromo)stearoyl-sn-glycero-3-
phosphocholine (850480) and 1-palmitoyl-2-(9,10-dibromo)stear-
oyl-sn-glycero-3-phosphocholine (850481).
Trypanosome Killing Assays
Light microscopy based trypanosome killing assays were
performed as previously described in detail [6,10,21,22]. Meta-
cyclic Trypanosoma brucei brucei strain STIB247 were obtained from
dissection of the salivary glands of infected tsetse flies. Newly
hatched Glossina morsitans morsitans (24–48 h post eclosion) were fed
two defibrinated horse blood meals containing 26106 mL-1
trypanosomes on two separate days. Flies were then maintained
at 25uC in 75 % relative humidity and fed maintenance blood
meals three times per week. Following day 20–30, flies were
harvested and salivary glands were dissected out and placed into
HMI 9 media containing 10 % fetal bovine serum for 30 minutes.
Metacyclic cells were expelled into the media by the residual
peristalsis of the salivary glands. Cells were collected via
centrifugation and maintained in HMI 9 media with 20 % fetal
bovine serum at 37uC in 5 % CO2 until use. Killing assays were
conducted with 16104 cells/mL in HMI 9 media containing 10 %
fetal bovine serum. Live cells were scored via hemocytometer after
2 h incubation. Trypanosoma vivax strain ILRAD V34 and
Trypanosoma congolense strain IL3000 were grown from stabilites in
donor ICR mouse (Harlan, United Kingdom). Parasites were
harvested from mice by terminal exsanguination and subsequent
differential centrifugation of the blood with an equal volume of
HMI 9 media to form a buffy coat layer. Cells were maintained in
HMI 9 with 20 % fetal bovine serum at 37uC in 5 % CO2 until
use. Killing assays were performed with 16107 cells/mL in HMI 9
media with 20 % bovine serum. Cells were incubated at 37uC for
2 h and live cells were scored visually via hemocytometer. All
assays were conducted in at least duplicate, and data points are the
averages with standard deviations.
Anisotropy Assays
The plasma membrane rigidity of live T. b. brucei was determined
by measuring the fluorescence depolarization of diphenyl-1,3,5-
hexatriene p-toluenesulfonate (DPH) or 1-(4-trimethylammonium-
phenyl)-6-diphenyl-1,3,5- hexatriene p-toluenesulfonate (TMA-
DPH; Invitrogen T204). Cells were washed 3 times with and
resuspended in phosphate buffered saline at a density of 36106 cells/
mL. The anisotropic probes were added to a final concentration of
0.5 mM and allowed to intercalate into the cell membrane for 1 h in
the dark. Anisotropic values were acquired via the software function
of a PerkinElmer Life Sciences LS55 spectrofluorometer. Samples
were excited at 358 nm, and emission was read at 430 nm, with 10-
nm excitation and emission slit widths. Temperature was main-
tained at 37uC by means of the PerkinElmer LS55 Biokinetics
accessory. Data were corrected for light scattering with an unlabeled
sample of cells, and anisotropy was calculated according to the
equation r = (IVV - GIVH)/(IVV + 2GIVH), where r is the anisotropy
value, IVV is the emission intensity acquired with the excitation- and
emission-polarizing filters set vertically, G is the instrument
correction factor, and IVH is the emission intensity acquired with
the excitation-polarizing filter set vertically and the emission-
polarizing filter set horizontally. Data points shown are the average
of triplicate measurements with standard deviations.
In-vivo Fluorescence Recovery after Photo Bleaching
(FRAP) Measurements
Bloodstream form T. b. brucei, strain 427, expressing VSG
MITat1.6 were cultivated in HMI 9 media with 10% fetal calf
serum. 16107 cells were washed three times with ice cold
trypanosome dilution buffer (TDB; 5 mM KCl, 80 mM NaCl,
1 mM MgSO4, 20 mM Na2HPO4, 2 mM NaH2PO4, 20 mM
glucose, pH 7.6). The cell density was adjusted to 16108 cells/mL
and labeling of surface proteins was achieved by incubation with
1 mM sulfo-NHS coupled Atto 488 fluorescent dye (ATTO-TEC
GmbH, Siegen) for 15 min on ice [23]. After incubation the cells
were washed three times with ice cold TDB to remove unbound
Novel Trypanocidal Peptides
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dye. Labeled T. b. brucei cells were incubated with 8 mM SHP-1 for
10 min at 37uC. The fluorescently labeled cells were mixed 1:3
with 10% Type-A gelatin from porcine skin (Sigma-Aldrich,
Steinheim) in PBS, pH 7.8, at 37uC. 4 mL of the cell gelatin
mixture was applied into a cover slide sandwich and mounted into
a temperature controlled sample holder. The sample holder was
cooled to 20uC until the cells were immobilized. Samples of SHP-1
treated and untreated MITat 1.6 wt cells were prepared identi-
cally. Line FRAP measurements were performed at a constant
temperature of 20uC. 10 pre-bleach and 100 post-bleach images
were recorded at 2fps. VSG mobile fractions were determined
according to Phair et al. (2004) [24] using double normalization.
The mobile fraction refers to the percentage of mobile VSG
molecules within the measured region. For example a mobile
fraction of 50 % means that half of the VSG molecules are mobile.
The relative frequency indicates the proportion of cells that exhibit
a given mobile fraction of VSG.
Trypanosome Motility
All images and videos were acquired with an Axio Observer Z1
equipped with an AxioCam MRm controlled by AxioVision 4.6
software. Videos were acquired with live cells at a density of 16107
cells/mL in HMI 9 media with 10 % fetal bovine serum,
incubated with 40 mM SHP at 37uC. Trypanosomes were
visualized at magnification 63 6 and videos were recorded with
100-ms acquisition times. The motility of BSF trypanosomes was
scored directly or from video playback. Trypanosome motility was
classified as normal, hyperactive or constricted as described
previously [10]. An example of a trypanosome scored as normal
is shown in Movie S1. Example hyperactive trypanosomes are
shown in Movies S2 and S3, while those exhibiting constricted
motility are exemplified by the representative trypanosome
presented in Movie S4. Data in figure 2D is shown as the average
of at least duplicate trials with standard deviations.
Parallax Analysis
The hydrocarbon penetration depth of tryptophans spaced
throughout synthetic peptides corresponding to SHP-1 or SHP-3
(Table S1) was determined by parallax analysis with brominated
phosphatidylcholine liposomes. Large unilamellar liposomes com-
posed of egg phosphatidylcholine and 10 mol % 1-palmitoyl-2-
(6,7-dibromo)stearoyl-sn-glycero-3-phosphocholine (shallow
quencher) or 1-palmitoyl-2-(9,10-dibromo)stearoyl-sn-glycero-3-
phosphocholine (deep quencher) were constructed by hydration
of a thin dry lipid film with phosphate buffered saline. Resulting
multilamellar liposomes were made unilameller via extrusion
through polycarbonate filters with 0.1 mm pores. Peptides
(500 nM) were incubated with 200 mg/ml liposomes in phosphate
buffered saline at 37uC for 22 h. Tryptophan fluorescence at
357 nm was measured from at least triplicate trials in the
PerkinElmer Life Sciences LS55 spectrofluorometer and an
excitation wavelength of 280 nm for SHP-1 and 290 nm for
SHP-2, 10 nm excitation and 9 nm emission slit widths. The
distance of tryptophans from the bilayer center (ZCF) is calculated
from the equation [12]:
ZCF~LC1z½-ln(F1=F2)=pC~L212=2L21
Where LC1 is the distance from the center of the bilayer to the
shallow quencher, in this case 10.8 A˚ for 6,7-dibromo-PC [25], F1
is the intensity of tryptophan in the presence of the shallow
quencher and F2 is the tryptophan intensity in the presence of the
deep quencher, C is the mole fraction of quencher divided by the
area of individual phospholipid (70 A˚2), and L21 is the difference in
the depth of the two quenchers (2.7 A˚) [25]. The hydrocarbon
insertion depth of tryptophans is then given by one half the bilayer
thickness, 29 A˚ [25], minus ZCF.
Circular Dichroism
Spectra were recorded with a Jasco J-710 spectropolarimeter in
a 1 mm quartz cuvette. Measurements were performed with a final
concentration of 15 mM SHP-1 added from a stock of ethanol-
solubilized peptide (final ethanol concentration 7.5 %) in 10 mM
K2PO4, 50 mM Na2PO4, pH 7.5. Lipid associated peptide spectra
were recorded with the addition of 0.1 mm unilamellar egg
phosphatidylcholine liposomes at a peptide to lipid ration of 0.3.
Spectra were averaged from four scans and the appropriate buffer
scans were subtracted.
Molecular Modeling
The tertiary structure of SHP-1 in a lipid environment was
predicted using the web-based molecular dynamics simulation
software PEPstr (http://www.imtech.res.in/raghava/pepstr/)
[26]. The per-atom charge and radius were calculated by
converting the PDB file obtained from PEPstr into a PQR file
via the web-based PDB2PQR server (http://kryptonite.nbcr.net/
pdb2pqr/) [27]. Values were calculated using the PARSE
forcefield. The peptide was subsequently visualized with the
PyMOL Molecular Graphics System, Version 1.4 (Schro¨dinger,
LLC).
Supporting Information
Figure S1 SHP binding to BSF T. b. brucei. FITC-labeled
SHP-1 (blue – ) and SHP-3 (green – ) were assayed for binding to
BSF T. b. brucei via flow cytometry (no peptide, red – ) .
Trypanosomes were adjusted to 36106 cells/ml in HMI 9 media
with 10 % fetal bovine serum, 8 mM FITC-SHP-1 or FITC-SHP-
3 was added and 50,000 cells were immediately counted.
(DOC)
Figure S2 Trypanosome killing and membrane interac-
tion with SHP tryptophan variants. (a) Small hydrophobic
peptide-1 tryptophan variants (Table S1) SHP-1DW1 (orangeX),
SHP-1DW8 (green &) and SHP-1DW18 (red m) were tested for
trypanocidal activity. (b) The ability of SHP-1 tryptophan
variants, 1 mM SHP-1DW1 (orange – ), 1 mM SHP-1DW8 (green
– ), 0.2 mM SHP-1 (blue – ) and 0.2 mM SHP-1DW18 (red – ), and
(c) SHP-3 tryptophan variants, 1 mM SHP-3DW1 (orange – ),
1 mM SHP-3 (blue – ), 1 mM SHP-3DW13 (red – ) and 4 mM
SHP-3DW20 (green – ), to interact with lipid bilayers was
determined by monitoring the release of entrapped calcein from
unilamellar egg phosphatidylcholine liposomes.
(DOC)
Table S1 Sequences and Quenching Data of SHP
Tryptophan Variants.
(DOC)
Methods File S1 Contains methods for supplementary
Figures S1 and S2.
(DOC)
Movie S1 Live, untreated BSF T. b. brucei exhibiting
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Movie S2 Live BSF T. b. brucei visualized via DIC video
microscopy approximately 30 sec after addition of
40 mM SHP-3. Cells exhibit hyperactivated motility.
(MOV)
Movie S3 Live BSF T. b. brucei visualized via DIC video
microscopy approximately 30 sec after addition of
40 mM SHP-3DR. Cells exhibit hyperactivated motility.
(MOV)
Movie S4 Live BSF T. b. brucei visualized via DIC video
microscopy approximately 10 min after addition of
40 mM SHP-3DR. Cells exhibit constricted motility.
(MOV)
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